Biomed Faculty Directory

Office of the Dean Administration Departments Research Alpert Medical School Giving

Jeffrey Mazer

Edit My Page

Title: Assistant Professor of Medicine
Department: Medicine

Jeffrey_Mazer@brown.edu
+1 401 793 4501

 
Overview | Grants/Awards | Publications

Biography

Dr. Mazer is an Assitant Professor of Medicine and a member of the Division of Pulmonary, Critical Care & Sleep Medicine. Dr. Mazer graduated from Tufts Medical School and completed residency in Internal Medicine at Brown. Following his Chief Residency, he completed fellowship training at Brown Pulmonary Critical. Dr. mazer joined the faculty of Rhode Island and Miriam Hospitals in 2009, with clinical duties in both Pulmonary and Critical Care Medicine. In June 2011 he was appointed as the Director of Pulmonary Rehabilitation.

Awards

Attending Teaching Award 2009, Alpert Medical School of Brown University 2011
Fellow Teaching Award 2009, Alpert Medical School of Brown University 2009
Dean's Teaching Award, Alpert Medical School of Brown University, 2007.
Haffenreffer Fellow in Medical Sciences, Alpert Medical School of Brown University 2005-6.

Affiliations

American Thoracic Society (2006 to present)
Society of Critical Care Medicine (2007 to present)
Graduate and Resident Education Committee of SCCM (2009-2012)

Selected Publications

  • Acute Respiratory Failure: Chapter 18. Comprehensive Review in Adult Critical Care Medicine 2012(2012)
  • Stone AJ, Machan JT, Mazer JM, Casserly B, Klinger JR. Echocardiographic Evidence of Pulmonary Hypertension is Associated with Increased One Year Mortality in Patients Admitted with Chronic Obstructive Pulmonary Disease. Lung. 2011 Jun;189(3):207-12.(2011)
  • Casserly B, Mazer JM, Vang A, Harrington EO, Klinger JR, Rounds S, Choudhary G. C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade. Life Sci. Sep 2011; 89: 460-6.(2011)
  • Vang A, Mazer JM, Casserly B, Choudhary G. Activation of endothelial BKCa channels causes pulmonary vasodilation. Vascular Pharmacology 2010; 53: 122–129.(2010)
  • Pulmonary Hypertension, Ferri's Clinical Advisor, Elsevier Science 2008(2008)
  • Altitude Sickness, Ferri's Clinical Advisor, Elsevier Science, 2008(2008)